Search Results

By Syed Ali Abutalib, MD; Katharina Fleischhauer, MD; and Ephraim Joseph Fuchs, MD, MBA  / June 25, 2025

HLA-Matching Considerations for Hematopoietic Cell Transplantation in Hematologic Malignancies

Besides relapse of the malignant disease, graft-vs-host disease is still one of the greatest concerns, in terms of adverse effects, following a hematopoietic cell transplantation (HCT) in a patient with a hematologic malignancy. To mitigate these concerns, investigators are continually analyzing ...